Portfolio

To address AMR and protect the lives of people around the world, PACE is providing funding and support for a portfolio of early-stage projects to help grow the pipeline of high-quality antimicrobial therapeutics and associated diagnostics.

Supporting the best innovations to address the global threat of AMR

We are supporting a diverse portfolio of projects aimed at developing new tests and treatments for bacterial infections with high unmet need. Through a series of funding rounds available to academics and SMEs worldwide, we are selecting, investing in and supporting the most promising projects. We are offering a collaborative approach to project development through access to advisors, mentors, potential project partners and enabling technologies and capabilities. By supporting the projects in this way, we are helping to give them the best chance of success and position them for onward funding, investment and development. More projects will enter the portfolio as the programme progresses. This page highlights the innovators and projects that are currently in the PACE portfolio.

11

Number of projects supported

£11m

PACE funds committed to projects

12

Number of organisations funded

Portfolio Projects


Filters
Active Closed Diagnostic Therapeutic

Clear filters

University of Sheffield

Project title: Towards new drugs for a novel target in Pseudomonas aeruginosa


Xiretsa

Project title: Development of anti-infective conjugated electrolytes (ACEs) as a novel class of antibiotic